Cardiorentis initiates first-ever acute heart failure Phase III clinical trial ... PharmiWeb.com (press release) Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular mortality. TRUE-AHF (TRial of Ularitide's Efficacy and safety in patients with ... |
